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Abstract
Advances in genomic profiling present new challenges of explaining how changes in DNA and 
RNA are translated into proteins linking genotype to phenotype. Here we compare the genome-
scale proteomic and transcriptomic changes in human primary hematopoietic stem/progenitor cells 
and erythroid progenitors, and uncover pathways related to mitochondrial biogenesis enhanced 
through post-transcriptional regulation. Mitochondrial factors including TFAM and PHB2 are 
selectively regulated through protein translation during erythroid specification. Depletion of 
TFAM in erythroid cells alters intracellular metabolism, leading to elevated histone acetylation, 
deregulated gene expression, and defective mitochondria and erythropoiesis. Mechanistically, 
mTORC1 signaling is enhanced to promote translation of mitochondria-associated transcripts 
through TOP-like motifs. Genetic and pharmacological perturbation of mitochondria or mTORC1 
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specifically impairs erythropoiesis in vitro and in vivo. Our studies support a mechanism for post-
transcriptional control of erythroid mitochondria and may have direct relevance to hematologic 
defects associated with mitochondrial diseases and aging.
Introduction
Cellular differentiation requires highly coordinated gene expression through transcriptional 
and post-transcriptional mechanisms. Advances in high-throughput sequencing enabled 
genome-scale quantification of mRNA for gene expression, yet the extent to which changes 
in mRNA are translated to protein remains unclear. Mass spectrometry (MS)-based 
proteomics provide an approach to globally interrogate protein abundance in human 
tissues1,2. We reasoned that comparing the proteomic and transcriptomic profiles might 
provide insights into the post-transcriptional pathways in developmental specification, which 
would otherwise have been overlooked using only transcriptome-based analysis.
The development of hematopoietic stem/progenitor cells (HSPCs) into lineage-committed 
cells serves as a paradigm for studying gene regulatory events governing cellular 
differentiation3. Among them, the specification of erythroid lineage is of particular 
importance. An exquisite coordination of erythroid maturation is essential for continuous 
production of red blood cells (RBCs), and their imbalance underlies the pathogenesis of 
various disorders including β-thalassemia and anemia of chronic disease4. Erythroid 
progenitors and erythroblasts are extraordinarily proliferative, while cell growth decreases 
dramatically in later maturation. As hemoglobin content reaches a threshold, erythroblasts 
enucleate to become reticulocytes, exit the bone marrow (BM), clear the transferrin 
receptors, and extrude the remaining organelles including mitochondria. Little is known 
about how differentiating erythroid cells coordinate programs of proliferation, maturation 
and metabolism with the changing environment and cellular processes.
Through an unbiased analysis of proteomic and transcriptomic changes during human 
erythropoiesis, we uncovered major pathways related to mitochondrial biogenesis enhanced 
through post-transcriptional pathways. In-depth molecular and genetic studies established a 
functional link between mitochondrial metabolism and epigenetic regulation required for 
normal erythropoiesis. Our results support a model in which the erythroid mitochondria are 
regulated by mTORC1-mediated protein translation and may have direct relevance to 
hematologic disorders associated with mitochondrial dysregulation.
Results
Comparative Proteomic and Transcriptomic Profiling of Erythropoiesis
Human CD34+ HSPCs were differentiated ex vivo into erythroid progenitors 
(proerythroblasts or ProEs) and late erythroblasts (ERYs)5 (Fig. 1a). Fetal or adult HSPCs 
(F0 or A0) and lineage-committed ProEs (F5 or A5) were selected for genome-scale 
quantification of proteins and mRNAs by MS-based proteomics and RNA-seq analysis, 
respectively (Fig. 1b). Proteomic profiling using multiplexed isobaric tags (iTRAQ) resulted 
in identification and quantification of proteins encoded by 14,502 genes, accounting for 
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72.4% of annotated protein-coding genes6 (Supplementary Table 1). Among them, 92.0% 
(13,341 of 14,502) were assigned to corresponding transcripts detected by RNA-seq (Fig. 
1c). The proteomic and transcriptomic profiling achieved comparable ranges of 
quantification (Fig. 1d). A survey of representative genes demonstrated reproducible 
increases in expression of erythroid-associated markers (CD36, CD71 and CD235a), 
hemoglobins (HBE1, HBG1, HBB and HBA1), transcription factors (TFs) (GATA1 and 
KLF1) and enzymes (CA1 and FECH) in ProEs relative to HSPCs. Similarly, the expression 
of HSPC-associated markers and TFs was significantly decreased in ProEs (Fig. 1e). In total, 
we identified 1,071 to 2,598 differentially expressed mRNAs (fold change ≥ 1.5, P-value ≤ 
0.01; Supplementary Fig. 1a-h and Table 2) and 393 to 1,663 differentially expressed 
proteins (fold change ≥ 1.3, P-value ≤ 0.01; Supplementary Fig. 1i-p and Table 3) associated 
with distinct biological processes between fetal or adult HSPCs and ProEs, respectively.
Post-Transcriptional Control of Proteins Associated with Mitochondrial Biogenesis
To compare mRNA and protein-level expression, we overlaid the transcriptomic and 
proteomic profiles between adult HSPCs (A0) and ProEs (A5) (Fig. 2a). Strikingly, 1,050 
out of 1,549 (67.8%) upregulated proteins were not paralleled by changes in cognate 
mRNAs. Similarly, 399 out of 785 (50.8%) downregulated proteins had no corresponding 
change in mRNAs. Similar patterns were observed between fetal HSPCs and ProEs 
(Supplementary Fig. 1r-t). We also identified differentially expressed mRNAs with no 
changes in proteins, consistent with regulation through mRNA stability, translation, and/or 
protein stability.
Hereafter we focused on adult HSPCs and ProEs. We categorized the upregulated genes into 
three groups (RNA-only, Both, and Protein-only; Fig. 2a; Supplementary Table 4) based on 
the changes in mRNA and protein expression. By gene ontogeny (GO), the ‘Both’ genes are 
highly associated with heme biosynthetic processes that are hallmarks of erythroid 
differentiation. Strikingly, the most enriched pathways in ‘Protein-only’ genes are related to 
mitochondrial biogenesis, including ATP biosynthesis, electron transport chain, and 
oxidative phosphorylation (Fig. 2b; Supplementary Fig. 2a-e). Known mitochondrial 
genes7,8 are enriched most significantly in the upregulated ‘Protein-only’ genes 
(Supplementary Figure 2f,g).
Notably, 25 of 48 proteins related to ‘ATP synthesis coupled electron transport’ were 
significantly upregulated with little or no changes in mRNAs in ProEs (Fig. 2c). Similarly, 
12 of 14 proteins related to ‘mitochondrial ATP synthesis coupled proton transport’ were 
markedly upregulated without changes in mRNAs (Fig. 2d). These findings were validated 
by quantitative RT-PCR (qRT-PCR) and Western blot analyses of major components of the 
mitochondrial H+-ATP synthases ATP5A1, ATP5B, ATP5D and ATP5O (Fig. 2e-g). Our 
results suggest that the expression of mitochondrial proteins is enhanced through post-
transcriptional mechanisms during erythropoiesis.
Mitochondria Are Highly Regulated During Erythroid Differentiation
Mitochondria are critical for heme and iron metabolism, yet their regulation during 
erythropoiesis remains elusive. We measured mitochondrial mass and activities in CD34+ 
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HSPCs, ProEs and late erythroblasts (Fig. 3a). Consistent with enhanced expression of 
mitochondrial proteins, we observed progressive increases in mitochondrial DNA (mtDNA), 
mitochondrial mass, membrane potential (MMP) and intracellular ATP during erythroid 
specification (days 3 to 7) before clearance of mitochondria upon terminal maturation (Fig. 
3b-e). By profilingof metabolites metabolites involved in major bioenergetic pathways, we 
observed progressive alterations of the central carbon and other metabolic pathways, such as 
purine and amino acid metabolism, during erythropoiesis (Fig. 3f,g). Moreover, mtDNA was 
significantly elevated during erythropoiesis in mouse fetal liver (FL) and BM (R2 and R3 
stages9; Supplementary Fig. 3).
TFAM and PHB2 Are Post-Transcriptionally Regulated During Erythropoiesis
We next surveyed annotated human TFs10,11 and identified 28 TFs whose proteins but not 
mRNAs were significantly increased during erythropoiesis (Fig. 4a). Notably, Prohibitin 2 
(PHB2) and mitochondrial transcription factor A (TFAM) were ranked second and third 
based on the significance of increased protein expression (Fig. 4a). TFAM is essential for 
transcription and replication of mitochondrial genome12,13, while PHB2 plays a critical 
scaffolding role on mitochondrial inner membrane. The expression of TFAM or PHB2 
proteins and mRNAs was validated by qRT-PCR and Western blot (Fig. 4b-d). TFAM and 
PHB2 proteins were also increased in mouse FL and BM erythropoiesis (Supplementary Fig. 
3). Furthermore, the half-lives of TFAM and PHB2 proteins, as determined by 
cycloheximide (CHX) chase experiments, were comparable between HSPCs and ProEs, 
suggesting that the elevated protein expression is not due to increased protein stability (Fig. 
4e,f).
TFAM and PHB2 Are Indispensable for Mitochondria and Erythropoiesis
To determine the role of TFAM and PHB2, we employed shRNA-mediated depletion (Fig. 
4g). TFAM or PHB2-deficient ProEs displayed significant decreases in mtDNA, 
mitochondrial mass, MMP, and ATP compared to control cells expressing the non-targeting 
shRNA (shNT) (Fig. 4h-j). By measuring the incorporation of the methionine analogue L-
homopropargylglycine (HPG)14, we observed markedly reduced rate of protein synthesis in 
TFAM or PHB2-depleted early (CD71+CD235a-) and late (CD71+CD235a+) erythroid 
progenitors (Fig. 4k). TFAM or PHB2 depletion impaired erythroid differentiation, 
proliferation and increased apoptosis (Fig. 4l-n). TFAM or PHB2-depleted cells appeared 
morphologically immature with decreased expression of hemoglobins and GATA1 
(Supplementary Fig. 4a-c). We then performed RNA-seq analysis of control, TFAM and 
PHB2-depleted CD71+CD235a+ cells. By gene-set enrichment analysis (GSEA)15, we 
observed that the mitochondrial8 and ProE-specific genes (Supplementary Table 2) were 
significantly downregulated whereas HSPC-specific genes (Supplementary Table 5) were 
upregulated in TFAM or PHB2-depleted cells (Fig. 4o). These findings demonstrate that 
TFAM or PHB2 loss impaired the silencing of HSPC genes and the expression of genes 
required for mitochondria and erythropoiesis.
TFAM Is Indispensable for Erythropoiesis In Vivo
To establish the in vivo function, we generated the erythroid-specific Tfam knockout (KO) 
mice by EpoR-Cre16. We found that the embryonic day (E)13.5 EpoR-Cre+;Tfamfl/fl 
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embryos (hereafter called Tfam KO) were pale and anemic compared to littermates (Fig. 5a). 
Tfam protein was absent in CD71+Ter119+ KO erythroid cells and reduced in EpoR-
Cre+;Tfamfl/+ (heterozygous KO or HET) erythroid cells (Fig. 5b). Consistent with the 
reduced size (Fig. 5a), the cellularity of Tfam KO fetal livers is 45% of the wild-type (WT) 
controls (Fig. 5c). Erythroid maturation can be analyzed by the expression of CD71 and 
Ter119 markers (R1 to R5)9 (Fig. 5d). Tfam KO led to substantial increases in R1 and R2 
cells and a marked decrease in R3 erythroid progenitors (Fig. 5e,f). Tfam HET mice 
displayed intermediate phenotypes. Tfam KO also led to decreased mitochondrial mass and 
significantly increased apoptosis (Fig. 5g,h; Supplementary Fig. 5).
We then performed RNA-seq of Tfam WT and KO CD71+Ter119+ E13.5 erythroid cells. We 
identified 106 significantly upregulated and 249 downregulated genes in Tfam KO 
(Supplementary Table 6). The downregulated genes are highly associated with mitochondrial 
metabolism (Fig. 5i,j). The mitochondrial signature genes8 and genes associated with 
reactive oxygen species, oxidative phosphorylation, arginine and proline metabolism were 
markedly downregulated in Tfam KO (Fig. 5k). Together these analyses provide compelling 
evidence that Tfam is indispensable for proper control of metabolism and gene expression 
during erythropoiesis in vivo.
TFAM Loss Leads to Altered Metabolism and Histone Hyperacetylation
Changes in metabolism often result in altered epigenetic regulation17. We then measured 
histone modifications and observed significant increases in the levels of acetylated histones 
in TFAM-deficient erythroid cells (Fig. 6a; Supplementary Fig. 6a-d). Acetylated histones 
including H3K27ac are associated with gene activation. By ChIP-seq, we observed that 
TFAM depletion led to markedly increased H3K27ac at the promoters of the HSPC-specific 
genes (Fig. 6b,c; Supplementary Fig. 6e), consistent with the increased expression of HSPC 
genes. In total, 1,214 ChIP-seq peaks showed upregulated H3K27ac in TFAM-deficient 
erythroid cells (Fig. 6d). The upregulated peaks were highly associated with lymphoid 
development and hematopoiesis (Fig. 6e), suggesting that histone hyperacetylation results in 
altered epigenetic regulation.
To establish the causality, we performed metabolomic analysis and identified 32 and 39 
significantly upregulated and downregulated metabolites in TFAM-depleted erythroid cells 
(Fig. 6f,g; Supplementary Fig. 6f,g). Notably, β-hydroxybutyrate (βOHB) was among the 
most upregulated metabolites. The ketone body βOHB is synthesized from acetyl-CoA by β-
hydroxybututyrate dehydrogenase as alternative energy source18. Importantly, βOHB and 
the related butyrate are potent inhibitors of class I and II histone deacetylases (HDACs)18. 
Thus, our results suggest that the increased histone acetylation may be due to HDAC 
inhibition. Consistently, TFAM depletion led to significantly decreased HDAC activities 
(Fig. 6h). The level of acetyl-CoA was also lower (Fig. 6i), suggesting that the increased 
histone acetylation was not due to enhanced histone acetyltransferase activity19. 
Furthermore, human erythroid cells treated with βOHB or butyrate markedly enhanced 
histone acetylation, increased expression of the HSPC gene GATA2 and impaired erythroid 
differentiation in a dose-dependent manner (Fig. j-l).
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Together our results suggest that loss of TFAM causes defective mitochondria and 
metabolism, resulting in increased βOHB and HDAC inhibition. Increased histone 
acetylation interferes with the developmental silencing of HSPC genes, resulting in impaired 
erythroid gene expression and differentiation. Hence, our findings provide a molecular link 
between mitochondrial biogenesis, metabolism and epigenetic regulation required for 
normal erythropoiesis (Fig. 6m).
Translation of Mitochondria-Related mRNAs is Enhanced During Erythropoiesis
Increased translation provides an efficient way to control protein production in stem cells14 
and cancer20,21. We hypothesized that mitochondria-associated mRNAs are regulated 
through enhanced protein translation during erythropoiesis. Consistently, the rate of protein 
synthesis was the lowest in CD34+ HSPCs and increased by 2.1-fold in differentiated CD34- 
populations (Fig. 7a). Importantly, protein synthesis was increased by 1.8 and 2.5-fold in 
early (CD71+CD235a-) and late (CD71+CD235a+) erythroid progenitors, suggesting that 
erythroid differentiation from HSPCs is accompanied by enhanced protein translation. 
Furthermore, we performed polysome profiling and observed increased polysome size, 
indicating enhanced protein translation in ProEs relative to HSPCs (Fig. 7b). By qRT-PCR 
analysis of the polysomal fractions, we observed enhanced translation of mitochondria-
related mRNAs in ProEs, as illustrated by a shift of these mRNAs towards larger polysomes 
(Fig. 7c). The translation of GATA1 but not ACTB was also increased, suggesting that 
erythroid differentiation is accompanied by enhanced translation of a subset of, but not all, 
mRNAs.
Enhanced mTORC1 Signaling Regulates Mitochondrial Biogenesis During Erythropoiesis
The serine/threonine kinase mTOR is a major regulator of protein translation22. Genetic or 
pharmacologic perturbation of mTORC1, but not mTORC2, impaired erythroid development 
in mouse23,24. Activated mTORC1 phosphorylates 4EBP1 and S6K to promote protein 
translation25. Consistently, we observed a gradual increase of mTORC1 signaling, as 
measured by the levels of phosphorylated 4EBP1 and S6K, and mitochondrial proteins 
during erythroid differentiation (Fig. 7d). Moreover, HSPCs treated with rapamycin or 
active-site mTOR inhibitors (asTORi) PP24226 and Torin127 decreased 4EBP1 
phosphorylation and mitochondrial proteins, mtDNA, MMP, ATP, protein synthesis, and 
impaired erythroid differentiation (Fig. 7e-k and Supplementary Fig. 7d-f).
To assess the in vivo effects, we treated adult mice with PP242 and Torin1 (Fig. 7l). Acute 
mTORC1 inhibition had profound effects on 4EBP1 phosphorylation, TFAM and PHB2 
expression in CD71+Ter119+ erythroid cells (Fig. 7l), and decreased RBCs (Fig. 7m). While 
the BM cellularity remained unchanged, the frequencies of immature (CD71+Ter119+) and 
mature (CD71-Ter119+) erythroid cells were significantly lower in asTORi-treated mice 
(Fig. 7n). mTORC1 inhibition led to significant increased R1/R2 progenitors and decreased 
R3/R4 erythroid cells, similar to Tfam KO (Fig. 7o) and mice harboring deletion of the 
mTOR kinase28. Furthermore, mTORC1 inhibition significantly decreased mitochondrial 
mass and MMP in R2 and R3 cells (Fig. 7p,q), indicating that the erythroid commitment 
from R2 to R3 stages is selectively sensitive to mTORC1 inhibition.
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We next determined the effects of mTORC1 hyperactivation by depleting TSC1 and TSC2, 
the negative regulators of mTORC129. TSC1 or TSC2 depletion in erythroid cells 
significantly increased mtDNA, mitochondrial mass, and MMP (Fig. 7r; Supplementary Fig. 
7g-i). mTORC1 hyperactivation also impaired erythroid differentiation and increased 
apoptosis (Supplementary Fig. 7j,k) consistent with previous studies23, suggesting that the 
coordinated control of mTORC1 and mitochondria is essential for erythropoiesis. Similarly, 
hematopoietic-specific KO of Pten, a negative regulator of AKT and mTORC130, 
significantly augmented mitochondrial mass and impaired erythroid differentiation 
(Supplementary Fig. 7l,m). Additionally, overexpression of TFAM increased mtDNA and 
rendered erythroid cells less sensitive to mTORC1 inhibition (Supplementary Fig. 7n-t). 
Together our results demonstrate that mTORC1 inhibition impaired translation of 
mitochondria-associated proteins during erythropoiesis.
Translation of Mitochondria-Associated Proteins is Sensitive to mTORC1 Inhibition
To investigate whether erythroid mitochondria are selectively sensitive to mTORC1 
inhibition, we differentiated HSPCs into erythroid cells and granulocytes (Fig. 8a, 
Supplementary Fig. 8a-c). By polysome profiling, we observed that PP242 markedly 
inhibited protein synthesis in erythroid cells, as illustrated by decreased polysome content 
with a concomitant increase in the 80S peak (Fig. 8b). PP242 did not cause complete 
disassembly of polysomes, indicating that it selectively impaired a subset of mRNAs31,32. 
Notably, PP242 suppressed the translation of mitochondria-associated mRNAs by shifting 
these mRNAs towards lighter polysome and monosome fractions (Fig. 8c). In contrast, 
mTORC1 inhibition in granulocytes had minimal impact on polysome profiles or 
distribution of mitochondrial mRNAs. Granulocyte differentiation remained ostensibly 
normal upon mTORC1-inhibition or TFAM-depletion. Moreover, granulocyte-specific Tfam 
KO by Mrp8-Cre-ires-GFP33 had minimal effect on Mac1+Gr1+ granulocytes or the 
expression of granulocytic genes (Supplementary Fig. 8d-l), suggesting a distinctive 
requirement for Tfam in erythroid versus granulocyte differentiation.
We next performed iTRAQ-based proteomics of PP242-treated erythroid cells and 
granulocytes (Fig. 8d). Specifically, 935 proteins were significantly downregulated (fold 
change ≥ 1.3, P-value ≤ 0.01) in PP242-treated erythroid cells. Among them, 205 and 245 
are Protein-only (Fig. 2a) and mitochondria-associated genes7,8, which is significantly more 
enriched than genomic average. In contrast, among 529 downregulated proteins in PP242-
treated granulocytes, only 50 and 33 are Protein-only and mitochondrial genes, respectively. 
Specifically, the expression of mitochondria-associated proteins was downregulated in 
PP242-treated erythroid cells but not granulocytes (Fig. 8e). Moreover, mitochondria-
associated pathways were among the top enriched GO terms in downregulated proteins in 
erythroid cells but not granulocytes (Fig. 8f). These findings suggest that mitochondria-
associated mRNAs are selectively sensitive to enhanced protein translation in erythroid cells.
Mitochondria-Associated mRNAs are Regulated by mTORC1
Transcripts regulated by mTORC1 typically have 5′ terminal oligopyrimidine (TOP) or 
TOP-like motifs32 consisting of at least five pyrimidines within four nucleotides of 
transcription start site (TSS). By mapping TSS using dbTSS34, RefSeq and Ensembl, we 
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found that TFAM, PHB2, ATP5A1, ATP5B and ATP5D transcripts contain TOP or TOP-like 
motifs, whereas ATP5O contains a translation initiator of short 5′UTR (TISU) motif found 
in mTOR-sensitive non-TOP mRNAs35-37 (Fig. 8g). The Protein-only genes were 
significantly enriched with TOP-like motifs (Fig. 8h).
To test the role of TOP-like motifs, we engineered TFAM, PHB2 and ATP5D 5′UTRs 
containing the wild-type (WT) or mutated (MUT) TOP-like motifs to a GFP reporter and a 
TK promoter (Fig. 8i and Supplementary Fig. 8m). Upon integration into erythroid cells, the 
MUT sequences decreased GFP expression compared to WT. Notably, PP242 treatment led 
to significant downregulation of GFP containing WT but not MUT 5′UTRs, suggesting that 
the TOP-like motifs mediate the modulation of protein translation by mTORC1. In contrast, 
the expression of GFP remained low and unchanged in granulocytes in the presence or 
absence of PP242.
Our results support a model that mitochondrial biogenesis is coordinately regulated through 
mTORC1-mediated protein translation during erythropoiesis (Fig. 8j). Specifically, as 
erythroid cells differentiate, they acquire erythropoietin (Epo) responsiveness, accumulate 
iron, and become highly proliferative. Both Epo and iron activate mTORC123,38, which 
phosphorylates 4EBP1 and S6K to promote synthesis of mitochondrial proteins. Stimulating 
mitochondrial activity engenders not only intracellular metabolism, but also increased ATP 
to fuel increasing cellular processes such as hemoglobin synthesis. Thus our studies identify 
an essential role for the mTORC1-mitochondria axis in coordinating protein translation and 
energy metabolism. Mitochondrial dysfunction leads to a variety of human disorders with 
impaired erythropoiesis being a severe manifestation in a subset of these diseases. Our 
findings may have direct relevance to the hematologic defects associated with mitochondrial 
diseases and aging.
Discussion
Here we describe the genome-scale comparison of transcriptomic and proteomic changes 
during human erythropoiesis, and identify mTORC1 as a major modulator of mitochondrial 
biogenesis. mTORC1 signaling is enhanced through Epo-JAK-AKT signaling38 or 
intracellular iron23 during erythroid differentiation. Elevated mTORC1 increases the 
translation of mitochondrial mRNAs through the TOP-like motifs, resulting in enhanced 
mitochondrial activities. mTORC1 also inhibits autophagy, a major pathway in mitochondria 
degradation39. Moreover, mTORC1 promotes mitochondrial function through YY1-PGC1α 
and HIF1α transcriptional complex40,41. Hence, it is likely that mTORC1 stimulates 
mitochondrial function by orchestrating translation and transcription of distinct 
mitochondria-related genes.
Accumulating evidence indicates that deregulated protein translation underlies many blood 
disorders. Of note, 5q-syndrome and Diamond-Blackfan anemia (DBA) are caused by 
ribosomal protein haploinsufficiency42, and can be ameliorated by L-leucine which activates 
mTORC1 signaling43-45. Thus, our findings suggest that inhibition of mTOR not only 
impacts protein translation45, but also mitochondrial biogenesis resulting in energy 
imbalance and metabolic dysfunction. Paradoxically, mTORC1 is viewed as a general 
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regulator of protein translation. How and why are erythroid cells specifically sensitive to 
mTORC1? By comparing two hematopoietic lineages, we provide evidence that 
mitochondrial protein translation and erythropoiesis are selectively sensitive to mTORC1. 
First, polysome analysis showed increased translation of mitochondria-associated proteins in 
erythrocytes but not granulocytes. Second, TFAM depletion or mTORC1 inhibition impaired 
mitochondria and erythropoiesis, whereas granulocytes were largely spared. Third, acute 
inhibition of mTORC1 in mice impaired erythropoiesis with minimal impact on other 
hematopoietic lineages. Finally, while Tfam KO was incompatible with erythropoiesis, 
granulocytes remained ostensibly normal.
Our studies suggest that enhanced mitochondrial biogenesis may be a unique feature of 
erythropoiesis. Developing erythrocytes are characterized by increasing heme and iron-
sulfur cluster biosynthesis in the mitochondria. TFAM-deficient erythroid cells failed to 
silence HSPC-specific genes, increased histone acetylation, and displayed defective 
metabolism. Most importantly, the ketone body βOHB, a marker of mitochondrial 
deficiency in human, was significantly upregulated which functions as a potent HDAC 
inhibitor. Increased βOHB impaired erythroid differentiation and gene expression similar to 
TFAM-depletion or mTORC1-inhibition. Therefore, our findings provide a molecular link 
between mitochondrial biogenesis, metabolism and epigenetic regulation indispensable for 
erythropoiesis. Furthermore, our findings provide a mechanistic explanation for the broader 
notion that RBCs are uniquely sensitive to deregulated protein translation and/or 
mitochondria. In light of recent development of inhibitors for protein translation46, our study 
raises the possibility that modulation of mitochondrial protein translation may provide 
therapeutic opportunities for hereditary anemias and mitochondria-based syndromes. 
Finally, our results demonstrate how unbiased analysis of proteomic and transcriptomic 
profiles may identify pathways in cellular regulation. With the increasing availability of 
genomic and proteomic landscapes, the integrative approach developed here can be extended 
to the systematic investigation of the gene-protein-pathway networks in health and disease.
Methods
Cells and cell culture
Human adult CD34+ HSPCs were obtained from the Fred Hutchinson Cancer Research 
Center. Fetal liver CD34+ HSPCs were isolated as described1. ProEs were generated as 
described2. Briefly, CD34+ HSPCs were cultured in StemSpan SFEM with 1xCC100 
cytokine cocktail (StemCell Technologies Inc.) and 2% penicillin-streptomycin for 6 days 
with media changes every 2∼3 days. On day 6, cells were transferred into StemSpan SFEM 
with 2% penicillin-streptomycin, Epo (1U/ml), IL-3 (5ng/ml), SCF (20ng/ml), 
dexamethasone (2μM) and β-estradiol (1μM) with media changes every 2∼3 days. Primary 
granulocytes were generated from CD34+ HSPCs as described3 with modifications. Briefly, 
HSPCs were expanded in StemSpan SFEM with 1xCC100 and 2% penicillin-streptomycin 
for 3 days. Cells were transferred to IMDM with 10% fetal bovine serum (FBS), IL-3 
(100ng/ml) and SCF (100ng/ml) for 3 days. Cells were then transferred to IMDM with 10% 
FBS, IL-3 (100ng/ml), SCF (100ng/ml) and G-CSF (10ng/ml), and maintained at 2∼8×105 
cells/ml with media changes every 2∼3 days. Maturing granulocytes (neutrophils) typically 
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emerge by 7∼10 days and can be cultured up to 14 days. For mTORC1 inhibition, cells were 
treated with control (DMSO), PP242 (2.5 and 10μM), Torin1 (0.25 and 1μM) or rapamycin 
(10nM, 100nM and 1μM) for 5∼7 days. No cell lines used in this study were found in the 
database of commonly misidentified cell lines that is maintained by ICLAC and NCBI 
BioSample. All cell lines were tested for mycoplasma contamination.
Mice
To obtain Tfam conditional knockout mice, the Tfamfl/fl mice4 were crossed with the EpoR-
Cre knock-in mice5 or the Mrp8-Cre-ires-GFP transgenic mice6. To obtain Pten conditional 
knockout mice, the Ptenfl/fl mice7 were crossed with the Mx1-Cre mice8. Pten deletion was 
achieved by intraperitoneal (i.p.) administration of five doses of polyI-polyC (0.8μg/g of 
body weight). PP242 and Torin1 were prepared at 1mg/ml and 2mg/ml in PBS with 5% 
PEG400 and 5% Tween80, and administrated via i.p. injection daily at 10mg/kg and 
20mg/kg for 3 days, respectively. All experiments were performed with the approval of the 
University of Texas Southwestern Institutional Animal Care and Use Committee.
Quantitative proteomics analysis
Proteomic analysis was performed as described with modifications9. We optimized major 
components of the platform to achieve genome-scale coverage. First, we used high-pH 
reversed phase (RP) and strong anion exchange (SAX) separation stages coupled with a 
narrow-bore extended-length low-pH RP column to achieve temporal separation of peptides 
in a nanoflow regime. Second, we chose the final dimension column geometry to maintain 
the integrity of chromatopgraphic separation at ultra-low effluent flow rates to maximize 
electrospray ionization efficiency. Third, we implemented separation stages in 
microcapillary format coupled to the mass spectrometer, thus providing automated and 
efficient transfer of peptides across all separation stages.
Sample preparation for DEEP SEQ analysis—Proteins were extracted with 8M urea 
in 0.1M NH4HCO3, reduced by 10mM Dithiothreitol (DTT) for 60min, and alkylated by 
20mM methyl methanethiosulfonate (MMTS) for 30min. After overnight trypsin digestion 
at 37°C, the peptides were cleaned using SepPak C18 RP cartridges (Waters Corp.), labeled 
with 4-plex iTRAQ reagents (AB Sciex), mixed and loaded into an online chromatography.
Multi-dimension separation and data acquisition—Nanoscale three dimensional 
online chromatography consists of first dimension RP column (200μm I.D. capillary packed 
with 20cm of 5μm dia. XBridge C18 resin), second dimension SAX column (200μm I.D. 
20cm of 10μm dia. POROS10HQ resin) and third dimension RP column (25μm I.D. 120cm 
of 5μm dia. Monitor C18, integrated 1μm dia. emitter tip). The final dimension ran at 
∼5nl/min with a 600min gradient from 2% A to 50% B (A=0.1% formic acid, B=acetonitrile 
with 0.1% formic acid). The downstream TripleTOF 5600+ (AB Sciex) was set in 
information dependent mode (IDA). Top 50 precursors (charge state +2 to +5, >100 counts) 
in each MS scan (800ms, scan range 350-1500m/z) were subjected to MS/MS (minimum 
time 140ms, scan range 100-1400m/z). Electrospray voltage was 2.2kV.
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Data processing and protein identification—MS data was subjected to search against 
SwissProt database with ProteinPilot V.4.5 (AB Sciex) with the search parameter ‘iTRAQ 4-
plex (peptides labeling) with 5600 TripleTOF’. The peptide spectra match (PSM) false 
discovery rate (FDR) ≤ 1% was used to filter peptides. We then summed the intensity of 
each iTRAQ reporter ion for the peptides assigned to single gene to generate a ratio for each 
gene.
Protein quantification—To determine the significance of the differences in protein 
expression, we used a statistical model as described10 with modifications. Specifically, two 
hypotheses are used: (1) the log2 ratio of a non-differentially expressed gene's protein counts 
in two samples follows normal distribution N(0, σ2), in which 0 is the mean and σ2 is the 
variance that decays exponentially with the gene's average signal intensity10; and (2) the 
majority of genes are non-differentially expressed. In this model, a sliding window of 500 
genes moving along the axis of log10(intensity) was introduced and the distribution of log2 
ratio of genes was considered as a mixture of the normal distribution N(0, σ2) contributed by 
non-differentially expressed genes and log2 ratio far from 0 contributed by differentially 
expressed proteins. To get the σ, we applied linear regression between the percentiles of the 
log2 ratio against the theoretical percentiles of normal distribution N(0, 1) from 25% to 75%. 
The slope was taken as an approximation of the σ of the normal distribution followed by the 
underlying non-differentially expressed proteins. We fitted an exponential decay function σ2 
= β × exp(α × log10(average intensity of window)) between the σ2 of each window and the 
average intensity of the proteins. Finally, the σ2 of each gene is calculated from the 
exponential decay function to measure the technical variations and to determine the 
significance (P-value) of its log2 ratio. A protein was considered to be differentially 
expressed if the following criteria were met in at least two out of the five replicates: (1) 
iTRAQ intensity ≥ 300; (2) iTRAQ ratio ≥ 1.3; and (3) P-value ≤ 0.01. However, because 
peptide ratios measured by MS can be distorted during precursor ion isolation11, the 
variation in some protein expression may be substantially underestimated. The proteomic 
experiments were performed as five independent proteome measurements and biological 
triplicates for the erythroid differentiation experiments. We identified 461,962 distinct 
peptides (FDR≤1%) from 12,892,243 spectra. After removing genes with weak 
quantification signal (iTRAQ intensities < 300), we achieved high-quality quantification of 
proteins encoded by 14,502 genes from 350,843 unique peptide sequences, accounting for 
72.4% of annotated RefSeq genes12.
Polysome profiling
Polysome profiling was performed as described with modifications13. Briefly, cells were 
treated with 100μg/ml cycloheximide (CHX) for 5min, harvested, washed twice with PBS 
containing 100μg/ml CHX, and centrifuged at 300×g for 5min at 4oC. Cells were 
respuspended in 425μl hypotonic buffer (5mM Tris-HCl pH7.5, 2.5mM MgCl2, 1.5mM 
KCl, protease inhibitor cocktail) and transferred to a pre-chilled 1.5ml tube. Then 5μl of 
10mg/ml CHX, 1μl of 1M DTT, and 100U RNase inhibitors were added to cells followed by 
vortexing for 5sec. Then 25ul of 10% Triton X-100 and 25μl of 10% sodium deoxycholate 
were added to cells followed by vortexing for 5sec. The supernatant were transferred to a 
pre-chilled 1.5ml tube after centrifugation at 21,000×g for 5min at 4oC. The same OD 
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amount of lysates from each sample were loaded onto a 10-50% sucrose gradient, and 
centrifuged at 35,000rpm for 2h at 4oC using SW40Ti rotor in a Beckman Coulter Optima 
L-80 ultracentrifuge with no brake. Samples were analyzed on the Bio-Rad BioLogic LP 
system and BioFrac fraction collector, and chased with 60% (w/v) sucrose with 
bromophenol blue at 1ml/min. Data were analyzed using the Bio-Rad LP Data View 
software. Polysome fractions were collected at 0.5 ml/fraction. For mTORC1 inhibition, 
cells were treated with DMSO or 2.5μM PP242 for 12h.
Measurement of protein synthesis
Protein synthesis was measured by the incorporation of L-homopropargylglycine (HPG)14. 
0.5∼1×105 CD34+ HSPCs or ProEs were plated in 100μl of methionine-free DMEM with 
200μM L-cysteine, 50μM 2-mercaptoethanol, 1mM L-glutamine, 0.1% BSA (Sigma) and 
appropriate cytokines. Cells were pre-cultured for 45min to deplete endogenous methionine, 
followed by 1h incubation with 1mM HPG. Cells were washed twice with PBS and fixed 
15min in 0.5ml of 1% paraformaldehyde in PBS on ice, followed by PBS wash and 
permeabilization in 200μl PBS containing 3% FBS and 0.1% saponin for 5min at RT. The 
Click-iT Cell Reaction Buffer Kit (Life Technologies) was used to conjugate azide to Alexa 
Fluor 488 or Alexa Fluor 555. After 30min, cells were washed twice in PBS containing 3% 
FBS and 0.1% saponin, resuspended in PBS containing 4μg/ml of 4′,6-diamidino-2-
phenylindole (DAPI), and analyzed by flow cytometry.
qRT-PCR and RNA-seq analysis
RNA was isolated using RNeasy Plus Mini Kit (Qiagen). qRT-PCR was performed using the 
iQ SYBR Green Supermix (Bio-Rad). RNA-seq library was prepared using the Truseq RNA 
Library Prep Kit (Illumina). For RNA-seq in HSPCs and ProEs, the raw reads were aligned 
to human genome (hg19) by TopHat15. Differentially expressed genes were identified by 
DEseq16 using fold change ≥ 1.5 and P-value ≤ 0.01. For RNA-seq in fetal liver 
CD71+Ter119+ erythroid cells, the reads were aligned to mouse genome (mm9) by 
TopHat15. Differentially expressed genes were identified by Cufflinks17 using fold change ≥ 
1.5 and P-value ≤ 0.05.
Western blot
Western blot was performed as described2 using the following antibodies: TFAM (7495S, 
Cell Signaling Technology; sc-23588, Santa Cruz Technology), PHB2 (14085S, Cell 
Signaling Technology), ATP5A1 (sc-136178, Santa Cruz Technology), ATP5B (sc-16690, 
Santa Cruz Technology), ATP5D (ab97491, Abcam), ATP5O (ab110276, Abcam, clone 
4C11C10D12), 4EBP1 (9644S, Cell Signaling Technology), phos-4EBP1 (Thr37/46) 
(2855S, Cell Signaling Technology), p70S6K (2708S, Cell Signaling Technology), phos-
S6K (Ser235/236) (2211S, Cell Signaling Technology), GATA1 (ab47490, Abcam), GATA2 
(ab22849, Abcam), TSC1 (6935, Cell Signaling Technology), TSC2 (4308, Cell Signaling 
Technology), H3K9ac (9649, Cell Signaling Technology), H3K27ac (8173, Cell Signaling 
Technology), H3K56ac (4243, Cell Signaling Technology), H4K5ac (ab51997, Abcam), 
H3K4me3 (9571, Cell Signaling Technology), H3K9me3 (13969, Cell Signaling 
Technology), H3K27me3 (9733, Cell Signaling Technology), H3K36me3 (4909, Cell 
Signaling Technology), H3 (4499, Cell Signaling Technology), ACTB (MAB1501, 
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Millipore, clone C4), and GAPDH (sc-26778, Santa Cruz Biotechnology). Densitometry 
quantification was performed using ImageJ software. All antibodies were used at 1:1,000 
dilutions except phos-4EBP1 (1:500), phos-S6K (1:500) and ACTB (1:2,500).
ChIP-seq analysis
ChIP-seq was performed as described2,18 using H3K27ac antibody (ab4729, Abcam) in 
K562 cells. ChIP-seq libraries were generated using NEBNext ChIP-seq Library Prep 
Master Mix (NEB). ChIP-seq raw reads were aligned to human genome (hg19) using 
Bowtie19, and peaks were identified using MACS20. Differentially enriched ChIP-seq peaks 
were identified using MAnorm18,21. MAnorm takes the chromosomal coordinates of all 
peaks and aligned reads in both samples as input. The (M, A) value of each peak was 
calculated and plotted, where M = log2(read density in shTFAM / read density in shNT) and 
A = 0.5×log2(read density in shTFAM x read density in shNT). Robust regression was 
applied to the (M, A) values of common peaks and a linear model was derived. The linear 
model was extrapolated to all peaks for normalization. The normalized M values represent 
log2-transformed fold changes of intensities at each peak between two samples. To identify 
upregulated or downregulated H3K27ac ChIP-seq peaks, we filtered the differentially 
enriched peaks based on M values (referred as MH3K27ac). For significantly upregulated or 
downregulated peaks, we kept H3K27ac peaks with |MH3K27ac| > 2; for shared H3K27ac 
peaks we used |MH3K27ac| ≤ 2.
Mitochondrial DNA, mass and membrane potential
Mitochondrial DNA (mtDNA) was determined using qPCR to measure the ratio of mtDNA 
versus genomic DNA. The primer sequences are in Supplementary Table 7. Mitochondrial 
mass was determined using flow cytometry. Briefly, 0.5∼1×106 cells were incubated with 
100nM MitoTracker Green (Invitrogen) and antibodies for cell surface markers for 30min at 
37oC, and analyzed on FACSCanto with 488nm excitation. Mitochondrial membrane 
potential (MMP) was monitored by JC1 staining. Briefly, 0.5∼1×105 cells were washed with 
PBS and resuspended in PBS containing 2μM JC1 and incubated at 37oC in 5% CO2 for 
15min. The control cells were incubated with 2μM JC1 with 10μM protonophore FCCP 
(carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone) for 15min. Cells were washed, 
resuspended, and analyzed on FACSCanto.
Intracellular ATP
Intracellular ATP was determined using the CellTiter-Glo Luminescent Cell Viability Assay 
(Promega) following manufacturer's protocol.
Metabolite profiling
Cells (3∼5×106) were harvested, washed twice with ice-cold saline, overlaid with 500μl of 
cold methanol/water (50/50, v/v), and subjected to three freeze-thaw cycles. After vortexing, 
the debris was pelleted by centrifugation at 16,000×g and 4°C for 15min and used for 
protein quantitation. The supernatant was dried using a SpeedVac concentrator, reconstituted 
in 100μl of 0.03% formic acid, vortex-mixed and centrifuged to remove debris. Targeted 
metabolite profiling of ∼200 water soluble endogenous metabolites was performed using a 
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LC-MS/MS approach. Separation was achieved on a Phenomenex Synergi Polar-RP HPLC 
column (150×2 mm, 4μm, 80Å) using a Nexera UHPLC system (Shimadzu Corporation, 
Kyoto, Japan). The mobile phases were 0.03% formic acid in water (A) and 0.03% formic 
acid in acetonitrile (B). The gradient program was as follows: 0-3min, 100% A; 3-15min, 
100%-0% A; 15-21min, 0% A; 21-21.1min, 0%-100% A; 21.1-30min, 100% A. The column 
was maintained at 35°C. Samples were kept in the autosampler at 4°C with 0.5ml/min flow 
rate and 10μl injection volume. The mass spectrometer AB QTRAP 5500 (AB SCIEX) was 
set in multiple reaction monitoring (MRM) mode. Sample analysis was performed in 
positive/negative switching mode. Declustering potential (DP) and collision energy (CE) 
were optimized for each metabolite by direct infusion of reference standards. The MRM 
MS/MS detector conditions were set as follows: curtain gas 30psi; ion spray voltages 1200V 
(positive) and -1500V (negative); temperature 650°C; ion source gas 150psi; ion source gas 
250psi; interface heater on; entrance potential 10V. The MRM transition (m/z) and CE (V) 
of each metabolite were optimized using standard compound. Dwell time for each transition 
was 3msec. MRM data was acquired using Analyst 1.6.1 software (AB SCIEX). 
Chromatogram review and peak area integration were performed using MultiQuant software 
version 2.1 (AB SCIEX). The peak area for each metabolite was normalized against the total 
ion current of all metabolites. The normalized area values were used as variables for the 
multivariate and univariate statistical analysis. All multivariate analyses were performed 
using SIMCA-P (version 13.0.1, Umetrics, Umeå, Sweden). The pre-processed datasets 
were mean-centered and unit-variance scaled, and evaluated by principal component 
analysis (PCA). Univariate statistical differences were analyzed using a Student's t-test.
Acetyl-CoA and HDAC assays
Acetyl-CoA was measured using the PicoProbe™ Acetyl-CoA fluorometric assay kit 
(BioVision K317-100). HDAC activity was measured using the HDAC activity colorimetric 
assay kit (BioVision K331-100). Specifically, 1.5 million cells were lysed and diluted to 
85μl in ddH2O in a 96-well plate. 10μl of 10×HDAC assay buffer and 5μl of the HDAC 
colorimetric substrate were added and mixed thoroughly. The plate was incubated at 37oC 
for 2h before adding 10μl of lysine developer. The plate was incubated at 37oC for 30min 
and measured at 405nm. HDAC activity was expressed as the relative O.D. value per mg of 
protein.
Lentiviral RNAi
Lentiviral RNAi was performed as described2. The shRNAs in the pLKO.1-puro vector for 
TFAM (sh1: TRCN0000016095; sh2: TRCN0000016093) and PHB2 (sh1: 
TRCN0000060920; sh2: TRCN0000060921) were obtained from Sigma-Aldrich. The 
shRNAs in the pGIPZ vector for TSC1 (sh1: V2LHS_92624) and TSC2 (sh1: 
V2LHS_233694; sh2: V2LHS_93624) were obtained from GE Dharmacon. Sequences of 
shRNAs are in Supplementary Table 7.
Flow cytometry
Cells were analyzed using FACSCanto (BD Biosciences) for expression of CD34, CD71, 
CD235a, or Ter119 conjugated to phycoerythrin (PE), fluorescein isothiocyanate (FITC), or 
allophycocyanin (APC; BD Pharmingen). Live cells were identified by exclusion of 7-
Liu et al. Page 14
Nat Cell Biol. Author manuscript; available in PMC 2018 January 17.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
amino-actinomycin D (7-AAD). Hematopoietic lineages in mouse BM were identified using 
markers for granulocytes (Gr1+Mac1+), macrophages (Mac1+F4/80+), immature 
(IgM-B220+) and mature B lymphocytes (IgM+B220+), immature (CD71+Ter119+) and 
mature erythroid cells (CD71-Ter119+). Data were analyzed using FlowJo software 
(Ashland, OR).
Cytospin and hematological indices
Cytocentrifuge preparations were stained with May-Grunwald-Giemsa as described22. 
Peripheral blood was isolated via the retro-orbital plexus and analyzed on a HEMAVET® 
HV950 (Drew Scientific, Inc.) as described22.
Code availability
Computation codes are available from the corresponding author on request.
Statistics and reproducibility
Data are represented as mean ± standard error of the mean (s.e.m.) or standard deviation 
(s.d.) of at least three independent experiments as specified in the figure legends. Graphs and 
statistical analysis were performed using the Microsoft Excel or GraphPad Prism software. 
Comparisons between groups were performed using the two-sided Student's t-test, repeated-
measures one-way ANOVA with Dunnett's correction, Fisher Exact t-test with Benjamini 
procedure, or hypergeometric distribution, as denoted in figure legends. The numbers of 
independent experiments or biological replicate samples and P-values (n.s. not significant, 
*P < 0.05, **P < 0.01, ***P < 0.001) are provided in individual figures. P < 0.05 was 
considered statistically significant. Panels in Figs 2f, 4c, e, g, 5a, b, d, 6a, j, 7d, e, l, and 8d, 
e, and Supplementary Figs 3a, c, f, h, 4b, 5a, c, e, 6b, 7d, g, n, and Supplementary Fig. 8a, h 
show a representative image or flow cytometry of at least three independent experiments or 
biological replicate samples. Analysis of gene expression was determined using the 2-ΔΔCt 
method with GAPDH as the reference gene unless otherwise specified. No statistical method 
was used to predetermine sample size in animal studies and the experiments were not 
randomized. The investigators were not blinded to allocation during experiments and 
outcome assessment.
Data availability
The RNA-seq datasets for human HSPCs (A0 and F0), ProEs (A5, F5, shNT, shTFAM and 
shPHB2), E13.5 fetal liver CD71+Ter119+ erythroid cells (Tfam WT and KO), and 
H3K27ac ChIP-seq datasets have been deposited in the Gene Expression Omnibus (GEO) 
under the accession number GSE86912. Mass spectrometry data have been deposited in 
ProteomeXchange with the primary accession code PXD006170. Source data for RNA-seq 
analysis are provided as Supplementary Tables 2, 4, 5 and 6. Source data for proteomic 
analysis are provided as Supplementary Tables 1, 3 and 4. Statistics source data for Figs 2e, 
g, 3b-g, 4b, d, f, h-n, 5c, e-h, 6g-l, 7a, c, f-k, m-r, and 8c, i, and Supplementary Figs 3b, d, e, 
g, i, j, 4c, 6a, c, d, f, 7a-c, e, f, h-m, o-t, and 8c, e-g, i-l are provided in Supplementary Table 
8. All other data supporting the findings of this study are available from the corresponding 
author on request.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Comparative Proteomic and Transcriptomic Analyses of Human Erythropoiesis
(a) Fetal and adult-stage CD34+ HSPCs were differentiated into ProEs ex vivo. Cells at 
matched stages of differentiation were collected for RNA-seq (n = 4 independent 
experiments) and proteomic (n = 5 independent experiments) analyses. (b) Schematic of 
iTRAQ-based quantitative proteomic analysis. (c) Venn diagram shows overlap between 
identified mRNA transcripts and proteins. (d) Overlay of RNA-seq and proteomic data 
demonstrates that the proteomic analysis achieved a comparable range of quantification as 
the RNA-seq-based transcriptomic profiling. RPKM, reads per kilobase of transcript per 
million reads. n = 4 independent RNA-seq experiments and n = 5 independent proteomic 
experiments. (e) Changes in expression of representative proteins between adult-stage 
HSPCs (A0) and ProEs (A5) are shown. Each color circle represents the measurement from 
an independent experiment. Boxes show the mean of the data and quartiles (n = 4 
independent RNA-seq experiments and n = 5 independent proteomic experiments). Whiskers 
show the minimum and maximum of the data.
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Figure 2. Comparative Transcriptomic and Proteomic Analyses Revealed Post-Transcriptional 
Control of Mitochondrial Pathways
(a) The correlation between RNA and protein-level expression changes in adult-stage 
HSPCs (A0) and ProEs (A5) is shown. Differentially expressed RNA transcripts and 
proteins (red, upregulated; blue, downregulated) were accessed for overlap. After filtering 
genes detected exclusively by RNA-seq or proteomics, 2,044 and 1,549 significant 
upregulated RNAs (RNA-all) and proteins (Protein-all) were identified, respectively. The 
differentially expressed genes were further divided into three groups based on significant 
changes at RNA (RNA-only), protein (Protein-only), and both levels, respectively. (b) GO 
enrichment analysis of protein and RNA expression changes. The green box highlights the 
top enriched GO terms for Protein-only genes. (c) Expression heatmap is shown for genes 
associated with ‘ATP synthesis coupled electron transport’. The Protein-only genes are 
shown on the bottom. n.d. not detected. (d) Expression heatmap is shown for genes 
associated with ‘Mitochondria ATP synthesis coupled proton transport’. (e) mRNA 
expression of representative Protein-only genes (ATP5A1, ATP5B, ATP5D and ATP5O) was 
measured by qRT-PCR in HSPCs and differentiating erythroid cells. Results are mean ± 
s.e.m. (n = 3 independent experiments). (f) Western blot analysis of representative Protein-
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only genes. (g) Quantification of Western blot analysis. Results are mean ± s.e.m. (n = 3 
independent experiments). Differences relative to HSPCs (day0) were assessed using a 
repeated-measures one-way ANOVA followed by Dunnett's test for multiple comparisons. 
*P < 0.05, **P < 0.01, ***P < 0.001 relative to HSPCs (day0) were considered significant. 
See Statistics Source Data in Supplementary Table 8. Unprocessed original scans of blots are 
shown in Supplementary Fig. 9.
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Figure 3. Dynamic Regulation of Mitochondria During Erythroid Differentiation
(a) Analysis of mitochondrial biogenesis and activities during human erythropoiesis. (b) 
Mitochondrial DNA (mtDNA) was determined using qPCR-based analysis to measure the 
ratio of mitochondrial DNA (ND1) versus genomic DNA (18S). The mtDNA content at 
various stages of erythroid differentiation relative to undifferentiated HSPC (day 0) is 
shown. (c) Mitochondrial mass was determined by flow cytometry using MitoTracker Green. 
The mitochondrial mass relative to undifferentiated HSPC (day 0) is shown. (d) Changes in 
mitochondrial membrane potential (MMP) was monitored by staining with JC1. Cells 
treated with the protonophore FCCP were analyzed as controls. All data are mean ± s.e.m. (n 
= 3 independent experiments) (b-d). (e) Changes in intracellular ATP during erythroid 
differentiation. Results are mean ± s.d. of n = 6 (day0) or n = 8 (day3 to day12) independent 
measurements pooled from 4 experiments. Differences relative to HSPCs (day0) were 
assessed using a repeated-measures one-way ANOVA followed by Dunnett's test for 
multiple comparisons (b-e). *P < 0.05, **P < 0.01, ***P < 0.001 relative to HSPCs were 
considered significant. (f) Principle component analysis (PCA) of metabolomic profiles in 
adult HSPCs (A0) and differentiating erythroid cells (A3, A5 and A12). n = 3 biological 
replicate samples for each group. (g) Heatmap is shown for metabolites with significant 
changes (see Methods) during erythropoiesis. Unsupervised clustering of metabolites 
according to the changes in their amounts during differentiation is shown. See Statistics 
Source Data in Supplementary Table 8.
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Figure 4. TFAM and PHB2 Are Post-Transcriptionally Regulated and Indispensable for 
Mitochondria and Erythropoiesis
(a) Heatmap is shown for transcription factors significantly upregulated at the protein but 
not mRNA levels. The genes are ranked based on the significance of fold changes in protein 
expression between HSPCs (A0) and ProEs (A5). n.d. not detected. (b) qRT-PCR analysis of 
TFAM and PHB2 in HSPCs and differentiating erythroid cells. (c) Western blot of TFAM, 
PHB2, GATA1 and GATA2 in HSPCs and erythroid cells. (d) Quantification of Western blot 
analysis. (e) The protein half-lives of TFAM and PHB2 were determined by CHX chase 
experiments. (f) Quantification of TFAM and PHB2 half-lives in HSPCs and ProEs. The 
dashed lines indicate the calculated half-lives for both proteins. Results are mean ± s.e.m. of 
n=3 independent experiments (b,d,f). Differences relative to HSPCs (day0) were assessed 
using a repeated-measures one-way ANOVA followed by Dunnett's test for multiple 
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comparisons. *P < 0.05, **P < 0.01, ***P < 0.001 (b,d,f). (g) Schematic of lentiviral 
shRNA-mediated depletion of TFAM or PHB2 in HSPCs, followed by erythroid 
differentiation (top). Validation of TFAM or PHB2 depletion by Western blot (bottom). Cells 
transduced with non-targeting shRNA (shNT) were analyzed as controls. The quantified 
protein expression of TFAM or PHB2 from three independent experiments is shown as mean 
± s.e.m. on the bottom. (h) Depletion of TFAM significantly decreased mtDNA (top). TFAM 
and PHB2 depletion significantly decreased mitochondrial mass (bottom). (i-n) Depletion of 
TFAM or PHB2 significantly decreased MMP (i), intracellular ATP (j), protein synthesis in 
CD71+CD235a- and CD71+CD235a+ erythroid progenitors (k), erythroid differentiation 
measured by the expression of CD34, CD71 and CD235a (l), proliferation (m), and 
increased apoptosis by AnnexinV and 7-AAD staining (n). Results are mean ± s.e.m. of n=3 
independent experiments (h,i,k-n) or mean ± s.d. of n=8 independent measurements from 
three experiments (j). Differences relative to shNT were assessed using a repeated-measures 
one-way ANOVA followed by Dunnett's test for multiple comparisons; *P < 0.05, **P < 
0.01, ***P < 0.001 (h-n). (o) GSEA analysis of mitochondrial genes, ProE or HSPC-
specific genes using the RNA-seq of shTFAM or shPHB2 relative to shNT, respectively. See 
Statistics Source Data in Supplementary Table 8.
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Figure 5. TFAM and PHB2 Are Required for Erythroid Development In Vivo
(a) Representative pictures of E13.5 Tfam WT and KO embryos (bottom) and fetal livers 
(top). Scale bar, 0.5cm. (b) Western blot of TFAM expression in WT, HET and KO 
CD71+Ter119+ E13.5 fetal liver erythroid cells. The quantified protein expression of TFAM 
is shown on the bottom as mean ± s.e.m of four independent samples for each genotype. (c) 
Total cell numbers in control (WT; n = 12), Tfam HET (n = 9) and KO (n = 5) E13.5 fetal 
livers. (d) Erythroid differentiation was assessed by expression of CD71 and Ter119. (e, f) 
The frequency and number of R1 to R5 cells in Tfam WT (n = 16), HET (n = 6) and KO (n 
= 4) E13.5 fetal livers. (g) Mitochondrial mass was determined by MitoTracker Green in 
Tfam WT (n = 16), HET (n = 6) and KO (n = 4) E13.5 erythroid cells. (h) Cell apoptosis in 
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Tfam WT (n = 6), HET (n = 5) and KO (n = 4) E13.5 erythroid cells. Results are mean ± s.d. 
(c, e-h) and analyzed by one-way ANOVA (c) or a two-tailed t-test (e-h) to evaluate the 
differences between WT and KO (or HET). *P < 0.05, **P < 0.01 were considered 
significant. (i) Top enriched gene ontogeny (GO) terms in significantly downregulated genes 
in Tfam KO erythroid cells. (j) Top enriched metabolic pathways in downregulated or 
upregulated genes in Tfam KO erythroid cells. (k) GSEA analysis of mitochondrial genes 
and other indicated signature genes downregulated or upregulated in Tfam KO erythroid 
cells. See Statistics Source Data in Supplementary Table 8. Unprocessed original scans of 
blots are shown in Supplementary Fig. 9.
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Figure 6. TFAM Depletion Leads to Altered Metabolism and Histone Hyperacetylation in 
Erythroid Cells
(a) Western blot of histone modifications in human erythroid (K562) cells transduced with 
TFAM shRNAs, control (shNT), or overexpression (OE) constructs. Quantification of 
Western blot is shown in Supplementary Fig. 6a. (b) The distribution of H3K27ac intensity 
at HSPC-specific genes. The average ChIP-seq intensity (RPKM) is shown between 5kb 
upstream of transcription start site (TSS) and downstream of transcription end site (TES). (c) 
H3K27ac ChIP-seq density plots are shown for three representative HSPC-specific genes. 
(d) Heatmap is shown for differentially enriched H3K27ac ChIP-seq peaks. 1,214 
upregulated and 644 downregulated H3K27ac peaks were identified with >4-fold changes in 
intensity between shTFAM and shNT. (e) Top enriched GO terms in genes associated with 
the upregulated or downregulated H3K27ac peaks. (f) Principle component analysis (PCA) 
of metabolomic profiles in K562 erythroid cells transduced with control or TFAM shRNAs. 
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n = 3 biological replicates per group. (g) Heatmap of the top 10 most upregulated or 
downregulated metabolites between control and TFAM-depleted erythroid cells. (h) HDAC 
activity in erythroid cells transduced with TFAM or control shRNAs. (i) Acetyl-CoA level in 
erythroid cells transduced with TFAM or control shRNAs. Results are mean ± s.e.m. of n=7 
(h) or n=5 (i) independent measurements. Differences relative to shNT were analyzed by a 
two-tailed t-test. *P < 0.05, **P < 0.01. (j) Western blot of H3K27ac and H3 in human 
primary erythroid cells treated with butyrate or β-hydroxybutyrate for 12h. Quantification of 
Western blot is shown on the top. Results are mean ± s.e.m. of n=3 experiments. (k) 
Erythroid differentiation was assessed by CD71 and CD235a. Results are mean ± s.e.m. of 
n=3 experiments. (l) mRNA expression of hemoglobin genes (HBA1 and HBB), GATA1 and 
GATA2. Results are mean ± s.e.m. of n=3 experiments. Differences relative to control cells 
(0mM) were assessed using a repeated-measures one-way ANOVA with Dunnett's test for 
multiple comparisons; *P < 0.05, **P < 0.01, ***P < 0.001 (j-l). (m) Schematic of changes 
in metabolism and histone acetylation in TFAM-deficient erythroid cells. See Statistics 
Source Data in Supplementary Table 8. Unprocessed original scans of blots are shown in 
Supplementary Fig. 9.
Liu et al. Page 29
Nat Cell Biol. Author manuscript; available in PMC 2018 January 17.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 7. mTORC1 Regulates Mitochondrial Biogenesis in Erythroid Cells
(a) Protein synthesis was assessed by HPG incorporation. Results are mean ± s.e.m. of n=3 
experiments. Differences relative to CD34+ were assessed using a repeated-measures one-
way ANOVA with Dunnett's test for multiple comparisons. **P < 0.01, ***P < 0.001. (b) 
Polysome profiling of HSPCs and ProEs. A representative profile is shown where the arrow 
represents the start of fraction. The positions of ribonucleoproteins (RNP), 80S ribosomes 
and polysomes are indicated. ABS254, absorbance at 254nm. (c) qRT-PCR analysis of 
polysome fractions in HSPCs and ProEs. Results are mean ± s.d. of n=4 measurements and 
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shown as the percentage (%) of total mRNA of all fractions combined. (d) Western blot 
analysis in HSPCs and erythroid cells. (e) HSPCs treated with control (DMSO), PP242 
(2.5μM) or Torin1 (0.25μM) during erythroid differentiation for 5∼7 days were analyzed by 
Western blot. (f-k) mTORC1 inhibition decreased mtDNA (f), MMP (g), ATP (h), protein 
synthesis (i), and impaired erythroid maturation (j) and gene expression (k). Results are 
mean ± s.e.m. of n=3 experiments (f,g,i-k) or mean ± s.d. of n=4 experiments (h). 
Differences relative to DMSO were assessed using a repeated-measures one-way ANOVA; 
*P < 0.05, **P < 0.01, ***P < 0.001 (f-k). (l) Schematic of mTOR inhibition. Western blot 
was performed using wBM or CD71+Ter119+ erythroid cells. (m) Blood counts in mice 
treated with Veh (n=7), PP242 (n=5) or Torin1 (n=5). (n) Frequencies of BM hematopoietic 
lineages in mice treated with Veh (n=6), PP242 (n=5) or Torin1 (n=5). (o) Erythroid 
differentiation was assessed by CD71 and Ter119. (p) Mitochondrial mass was determined 
by MitoTracker Green. (q) MMP was determined by JC1 staining. Results are mean ± s.e.m. 
of Veh (n=4), PP242 (n=3) or Torin1 (n=3), and analyzed by a two-tailed t-test; *P < 0.05, 
**P < 0.01 (m-q). (r) Depletion of TSC1 or TSC2 in erythroid cells increased mtDNA and 
mitochondrial mass. Results are mean ± s.e.m. of n=3 experiments. Differences relative to 
shNT were assessed using a repeated-measures one-way ANOVA. *P < 0.05, **P < 0.01. 
See Statistics Source Data in Supplementary Table 8. Unprocessed original scans of blots are 
shown in Supplementary Fig. 9.
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Figure 8. mTORC1 Selectively Regulates Protein Translation of Mitochondria-Associated 
mRNAs in Erythroid Cells
(a) Schematic of ex vivo differentiation of human primary HSPCs into ProEs or 
granulocytes. (b) A representative profile is shown for polysome profiling of human 
erythroid cells treated with control (DMSO) or PP242 (2.5μM) for 12h. (c) qRT-PCR 
analysis of indicated transcripts in cells treated with DMSO or PP242. Results are mean ± 
s.d. of n=4 independent measurements and shown as the percentage (%) of total mRNA of 
all fractions combined. (d) The number of downregulated proteins (fold change ≥ 1.3, P ≤ 
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0.01), Protein-only, or mitochondrial proteins were determined by iTRAQ-based proteomics 
in ProEs or granulocytes treated with PP242 (2.5μM) or control (DMSO) for 12h. P-values 
were calculated by hypergeometric distribution using All (n=935 and 529 in ProEs and 
granulocytes, respectively), Protein-only (n=205 and 50) and Mitochondria (n=245 and 33) 
genes. n.s. not significant. (e) The changes in the levels of indicated proteins were 
determined by iTRAQ-based proteomics in ProEs or granulocytes treated with PP242. 
Results are shown for one representative proteomic experiment. (f) Top enriched GO terms 
of proteins downregulated in PP242-treated ProEs or granulocytes. (g) The most frequent 
TSS of the indicated transcripts were annotated using dbTSS, RefSeq and Ensembl 
databases. The sequences of TOP, TOP-like or TISU motifs were shown as the pink color. 
(h) The frequency of TOP-like motifs in Protein-only, RNA-only or all genes. P-values were 
calculated by hypergeometric distribution using All (n=4,228 out of 6,624 total detected 
proteins), Protein-only (n=418 out of 594 total detected proteins) and RNA-only (n=363 out 
of 612 total detected proteins) genes. (i) Mutation of TOP-like motifs at the 5′UTRs of 
TFAM, PHB2 and ATP5D impaired GFP reporter expression in human primary erythroid 
cells but not granulocytes. Cells treated control (DMSO) or PP242 (2.5μM) for 12h were 
analyzed. Results are mean ± s.e.m. of n=3 independent experiments and analyzed by a two-
tailed t-test. *P < 0.05, **P < 0.01, n.s. not significant. See Statistics Source Data in 
Supplementary Table 8. (j) Model of mTORC1-mediated post-transcriptional control of 
mitochondrial biogenesis during erythropoiesis.
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